05.05.15
Terri Pascarelli has been appointed chief executive officer and member of the board of directors at AIT Bioscience, LLC. Ms. Pascarelli brings extensive business and entrepreneurial leadership to the company’s executive management team.
Ms. Pascarelli has held leadership positions with life science companies for more than 25 years. Prior to joining the company, she was vice president of client development for YourEncore, Inc., a consulting firm with offices in Indianapolis, Cincinnati and Princeton, NJ. She held executive leadership roles as president and chief operating officer of a venture-backed, Indiana-based pharma company and for a privately held Midwest medical lab. She also held leadership roles in strategy, sales and marketing, managed markets, R&D and commercial operations at Boehringer Ingelheim, Roche and AstraZeneca.
“When it comes to supporting biopharma drug development, AIT Bioscience is capable of finding the best solution for the situation, be it using LC-MS/MS for small molecule analysis or ligand binding analysis methods for large molecule analysis, or both,” said Ms. Pascarelli. “Delivering high quality bioanalytical service that is defined from the customer’s point of view is a big reason why I joined the company.”
AIT Bioscience is a bioanalytical lab serving U.S. and international biopharma and animal health companies engaged in drug development.
Ms. Pascarelli has held leadership positions with life science companies for more than 25 years. Prior to joining the company, she was vice president of client development for YourEncore, Inc., a consulting firm with offices in Indianapolis, Cincinnati and Princeton, NJ. She held executive leadership roles as president and chief operating officer of a venture-backed, Indiana-based pharma company and for a privately held Midwest medical lab. She also held leadership roles in strategy, sales and marketing, managed markets, R&D and commercial operations at Boehringer Ingelheim, Roche and AstraZeneca.
“When it comes to supporting biopharma drug development, AIT Bioscience is capable of finding the best solution for the situation, be it using LC-MS/MS for small molecule analysis or ligand binding analysis methods for large molecule analysis, or both,” said Ms. Pascarelli. “Delivering high quality bioanalytical service that is defined from the customer’s point of view is a big reason why I joined the company.”
AIT Bioscience is a bioanalytical lab serving U.S. and international biopharma and animal health companies engaged in drug development.